Home » Stocks » PDCO

Patterson Companies, Inc. (PDCO)

Stock Price: $35.35 USD 0.40 (1.14%)
Updated May 14, 2021 4:00 PM EDT - Market closed
Market Cap 3.42B
Revenue (ttm) 5.64B
Net Income (ttm) -481.36M
Shares Out 95.73M
EPS (ttm) -5.06
PE Ratio n/a
Forward PE 17.51
Dividend $1.04
Dividend Yield 2.94%
Trading Day May 14
Last Price $35.35
Previous Close $34.95
Change ($) 0.40
Change (%) 1.14%
Day's Open 35.29
Day's Range 35.02 - 35.53
Day's Volume 692,023
52-Week Range 14.10 - 37.16

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Patterson Companies (PDCO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in...

1 week ago - Zacks Investment Research

Patterson Cos. (PDCO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still t...

2 weeks ago - Zacks Investment Research

With yields as high as 7%, these investments can help accelerate your portfolio's growth.

Other stocks mentioned: ENB, K
2 weeks ago - The Motley Fool

West Point, NE, April 27, 2021 (GLOBE NEWSWIRE) -- Bridgepoint Investment Banking (“Bridgepoint”) acted as the sole financial advisor to Miller Veterinary Supply (“Miller”) on its announced sale to Patt...

2 weeks ago - GlobeNewsWire

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Veterinary Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced that it has signed an agreement to acquire substantially al...

2 weeks ago - Business Wire

As the markets take a step down, Q.ai's Artificial Intelligence has crunched the numbers to bring you today's Top Buys.

Other stocks mentioned: HOFT, LECO, MO, TGNA
1 month ago - Forbes

Patterson Cos. (PDCO) reported earnings 30 days ago.

1 month ago - Zacks Investment Research

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and robust product portfolio. However, high debt level remains a woe.

1 month ago - Zacks Investment Research

It's been a full year since the market hit its bottom. Today, Q.ai's Artificial Intelligence systems have assessed each firm to find the best top buys.

Other stocks mentioned: GNRC, LOW, PINC, VEC
1 month ago - Forbes

ST. PAUL, Minn.--(BUSINESS WIRE)--On March 16, 2021 the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) approved a new share repurchase authorization for up to $500 million of its common ...

1 month ago - Business Wire

3 Stocks to Capitalize on Promising Dental Supplies Industry

Other stocks mentioned: ABC, ALGN, BDX, CAH, COO, HSIC, LH ...
2 months ago - Zacks Investment Research

Patterson Companies' (PDCO) fiscal third-quarter 2021 results benefit from strong segmental performance.

2 months ago - Zacks Investment Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 13.73% and 4.12%, respectively, for the quarter ended January 2021.

2 months ago - Zacks Investment Research

Shares of Patterson Companies (NASDAQ:PDCO) were unchanged after the company reported Q3 results. Quarterly Results Earnings per share were up 23.40% year over year to $0.58, which beat the estimate of ...

2 months ago - Benzinga

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.55 billion (see attached Sales Summary for further details) in its fiscal third qua...

2 months ago - Business Wire

Patterson Companies (NASDAQ:PDCO) announces its next round of earnings this Wednesday, March 03. Here is Benzinga's everything-that-matters guide for this Wednesday's Q3 earnings announcement.

2 months ago - Benzinga

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect improvement at Dental segment.

2 months ago - Zacks Investment Research

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2021 third-quarter conference call on Wednesday, March 3, 2021 at 9 a.m. CT (10 a.m. ET)...

2 months ago - Business Wire

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

2 months ago - Zacks Investment Research

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

Other stocks mentioned: VIVO, XRAY
3 months ago - Zacks Investment Research

Is (PDCO) Outperforming Other Medical Stocks This Year?

4 months ago - Zacks Investment Research

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc., a distributor focused on providing the best products, technologies, services and business solutions to the animal and oral health markets, an...

4 months ago - Business Wire

Patterson Companies' stock performed similar to the stocks of Bed Bath & Beyond, GameStop or Owens & Minor. Although the stock price increased 150% since April 2020, the fundamental business provides no...

4 months ago - Seeking Alpha

Patterson Cos. (PDCO) reported earnings 30 days ago.

4 months ago - Zacks Investment Research

ST. PAUL, Minn.--(BUSINESS WIRE)--On December 15, 2020 the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) today declared a quarterly cash dividend of $0.26 per share. The dividend will b...

4 months ago - Business Wire

Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.

Other stocks mentioned: ALGN, WST
4 months ago - Zacks Investment Research

PDCO vs. ALGN: Which Stock Is the Better Value Option?

Other stocks mentioned: ALGN
5 months ago - Zacks Investment Research

Is (PDCO) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

Let's see if Patterson Companies (PDCO) stock is a good choice for value-oriented investors right now from multiple angles.

5 months ago - Zacks Investment Research

Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

5 months ago - Zacks Investment Research

Some stocks should move higher despite their recent rally.

Other stocks mentioned: STRT, UCTT
5 months ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for December 4th

Other stocks mentioned: ALTM, BRKS, SCHN
5 months ago - Zacks Investment Research

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q2 2021 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Patterson Companies' (PDCO) fiscal second-quarter 2021 results benefit from strong segmental performance.

5 months ago - Zacks Investment Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 65.79% and 8.81%, respectively, for the quarter ended October 2020.

5 months ago - Zacks Investment Research

Shares of Patterson Companies (NASDAQ:PDCO) moved higher by 0.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 61.54% over the past year to ...

5 months ago - Benzinga

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.55 billion (see attached Sales Summary for further details) in its fiscal second qu...

5 months ago - Business Wire

PDCO vs. MMSI: Which Stock Is the Better Value Option?

Other stocks mentioned: MMSI
5 months ago - Zacks Investment Research

Is (PDCO) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

5 months ago - Zacks Investment Research

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2021 second-quarter conference call on Wednesday, December 2, 2020 at 9 a.m. CT (10 a.m....

5 months ago - Business Wire

Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.

5 months ago - Zacks Investment Research

PDCO vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: COO
6 months ago - Zacks Investment Research

Is (PDCO) Outperforming Other Medical Stocks This Year?

6 months ago - Zacks Investment Research

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Other stocks mentioned: ABC, ALGN, BDX, CAH, COO, HSIC, LH ...
6 months ago - Zacks Investment Research

Patterson Cos. (PDCO) reported earnings 30 days ago.

7 months ago - Zacks Investment Research

ST. PAUL, Minn.--(BUSINESS WIRE)--The Board of Directors of Patterson Companies, Inc.

8 months ago - Business Wire

PHILADELPHIA, Sept. 5, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Patterson Companies, Inc.

8 months ago - PRNewsWire

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 50.00% and 4.75%, respectively, for the quarter ended July 2020.

8 months ago - Zacks Investment Research

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q1 2021 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

About PDCO

Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; technology solutions, such as practice management software and e-commerce solutions; patient education systems; and office forms and stati... [Read more...]

Industry
Medical Distribution
IPO Date
Oct 28, 1992
CEO
Mark Walchirk
Employees
7,800
Stock Exchange
NASDAQ
Ticker Symbol
PDCO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 17 analysts, the average rating for PDCO stock is "Hold." The 12-month stock price forecast is 33.67, which is a decrease of -4.75% from the latest price.

Price Target
$33.67
(-4.75% downside)
Analyst Consensus: Hold